4//SEC Filing
Trainer John 4
Accession 0001209191-21-039163
CIK 0001538210other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:06 PM ET
Size
6.9 KB
Accession
0001209191-21-039163
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Trainer John
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-06-08−3,432→ 106,381 totalExercise: $5.17Exp: 2030-03-04→ Common Stock (3,432 underlying) - Exercise/Conversion
Common Stock
2021-06-08$5.17/sh+3,432$17,743→ 58,338 total
Footnotes (1)
- [F1]This option vests as to 25% of the shares on January 8, 2021 with the remainder vesting in equal installments every month thereafter, beginning on January 8, 2021 and ending on January 8, 2024.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001843820
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:06 PM ET
- Size
- 6.9 KB